Jump Financial, LLC Catalent, Inc. Transaction History

Jump Financial, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Oct 21, 2024	SELL	$32.18 - $46.57 $2.84 Million - $4.11 Million	-88,285 Reduced 91.94%	7,735 $347,000
Q4 2023 Feb 07, 2024	BUY	$32.18 - $46.57 $248,912 - $360,218	7,735 New	7,735 $347,000
Q2 2023 Oct 21, 2024	BUY	$31.86 - $67.26 $3.06 Million - $6.46 Million	96,020 New	96,020 $4.16 Million
Q2 2023 Aug 07, 2023	BUY	$31.86 - $67.26 $3.06 Million - $6.46 Million	96,020 New	96,020 $4.16 Million
Q4 2022 Feb 13, 2023	BUY	$41.39 - $81.0 $2.89 Million - $5.66 Million	69,837 Added 125.19%	125,622 $5.65 Million
Q3 2022 Nov 07, 2022	BUY	$72.36 - $113.1 $4.04 Million - $6.31 Million	55,785 New	55,785 $4.04 Million
Q1 2022 May 12, 2022	SELL	$94.19 - $124.49 $183,293 - $242,257	-1,946 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$119.57 - $139.07 $232,683 - $270,630	1,946 New	1,946 $249,000
Q3 2021 Nov 12, 2021	SELL	$109.17 - $142.35 $285,152 - $371,818	-2,612 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$100.34 - $115.69 $262,088 - $302,182	2,612 New	2,612 $282,000
Q1 2021 May 17, 2021	SELL	$101.51 - $125.27 $257,530 - $317,809	-2,537 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$85.88 - $105.36 $217,877 - $267,298	2,537 New	2,537 $264,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.